First-line treatment for non-small cell lung cancer

被引：0
|
作者：
Pinn, Stephen
机构：
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2011年 / 72卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [21] Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Jahan, N.
    Swarup, S.
    Sultan, A.
    Naing, T.
    Mogollon-Duffo, F.
    Ball, S.
    Tun, A.
    Htut, T.
    Dash, A.
    D'Cunha, N.
    Hardwicke, F.
    Awasthi, S.
    Tijani, L.
    Thein, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S917 - S918
  • [22] BIWEEKLY CISPLATIN AND GEMCITABINE AS FIRST-LINE TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER
    Benekli, Mustafa
    Gunaydin, Yusuf
    Inanc, Mevlude
    Ozkan, Metin
    Demirci, Ayse
    Demirci, Umut
    Suner, Ali
    Karaca, Halit
    Tonyali, Onder
    Berk, Veli
    Buyukberber, Suleyman
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S563 - S563
  • [23] First-Line Therapy of Mutated Non-Small Cell Lung Cancer: An Update
    Stoehlmacher-Williams, Jan
    ONKOLOGIE, 2012, 35 (05): : 293 - 299
  • [24] First-line combination immunotherapy for metastatic non-small cell lung cancer
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 433 - 441
  • [25] Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer
    Yadollahi, Sina
    Harle, Amelie
    Gorf, Lauren
    Bayne, Mike
    Geldart, Thomas
    LUNG CANCER, 2022, 165 : S36 - S37
  • [26] Oral tyrosine kinase inhibitors in the first-line treatment of advanced non-small cell lung cancer
    Gori, Bruno
    Ricciardi, Serena
    Del Signore, Ester
    Fulvi, Alberto
    de Marinis, Filippo
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 : S55 - S60
  • [27] Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation
    Kelong Han
    Laurent Claret
    Alan Sandler
    Asha Das
    Jin Jin
    Rene Bruno
    BMC Cancer, 16
  • [28] Predictive model for response to first-line treatment for metastatic non-small cell lung cancer.
    Badawy, Ahmed Ashour
    Bae, Sejong
    Omar, Abbas
    Arafat, Waleed O.
    Khedr, Gehan Abd Elatti
    Grant, Stefan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer
    Montalar, J
    Morales, S
    Maestu, I
    Camps, C
    Vadell, C
    García, R
    Yuste, AL
    Torregrosa, D
    Segura, A
    LUNG CANCER, 2001, 34 (02) : 305 - 311
  • [30] Erlotinib as salvage treatment after failure to first-line gefitinib in non-small cell lung cancer
    Matthew K. Wong
    Alvis I. Lo
    Bing Lam
    W. K. Lam
    Mary S. Ip
    James C. Ho
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 1023 - 1028
12345